A PKPD mathematical model to determine efficacy of multiple doses of QGE031 (ligelizumab) vs. omalizumab and placebo in inhibiting skin responses in atopic asthmatics
- Resource Type
- Journal
- Source
EUROPEAN RESPIRATORY JOURNAL ; SEP 1 2015, 46 2p. Supplement: 59- Subject
- Language
- English
- ISSN
- 13993003